Search results for "pharmacology [Excitatory Amino Acid Antagonists]"

showing 10 items of 421 documents

sj-docx-5-tam-10.1177_17588359221110162 – Supplemental material for The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast ca…

2022

Supplemental material, sj-docx-5-tam-10.1177_17588359221110162 for The diagnostic accuracy of PIK3CA mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis by Antonio Galvano, Luisa Castellana, Valerio Gristina, Maria La Mantia, Lavinia Insalaco, Nadia Barraco, Alessandro Perez, Sofia Cutaia, Valentina Calò, Tancredi Didier Bazan Russo, Edoardo Francini, Lorena Incorvaia, Mario Giuseppe Mirisola, Salvatore Vieni, Christian Rolfo, Viviana Bazan and Antonio Russo in Therapeutic Advances in Medical Oncology

110203 Respiratory DiseasesFOS: Clinical medicine111702 Aged Health CareFOS: Health sciences111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified
researchProduct

Supplemental Material, Table_S2 - Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish

2020

Supplemental Material, Table_S2 for Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish by Chuanrui Zheng, Letian Shan, Peijian Tong and Thomas Efferth in Dose-Response

110320 Radiology and Organ ImagingFOS: Clinical medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
researchProduct

Supplemental Material, Table_S1 - Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish

2020

Supplemental Material, Table_S1 for Cardiotoxicity and Cardioprotection by Artesunate in Larval Zebrafish by Chuanrui Zheng, Letian Shan, Peijian Tong and Thomas Efferth in Dose-Response

110320 Radiology and Organ ImagingFOS: Clinical medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified
researchProduct

sj-pdf-2-imr-10.1177_0300060520982657 - Supplemental material for Evaluation of main functional dyspepsia symptoms after probiotic administration in …

2021

Supplemental material, sj-pdf-2-imr-10.1177_0300060520982657 for Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies by Lorenzo Drago, Gabriele Meroni, Dario Pistone, Luigi Pasquale, Giuseppe Milazzo, Fabio Monica, Salvatore Aragona, Leonardo Ficano, Roberto Vassallo and Gastrobiota Group in Journal of International Medical Research

111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 OtorhinolaryngologyFOS: Clinical medicine110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

sj-pdf-1-imr-10.1177_0300060520982657 - Supplemental material for Evaluation of main functional dyspepsia symptoms after probiotic administration in …

2021

Supplemental material, sj-pdf-1-imr-10.1177_0300060520982657 for Evaluation of main functional dyspepsia symptoms after probiotic administration in patients receiving conventional pharmacological therapies by Lorenzo Drago, Gabriele Meroni, Dario Pistone, Luigi Pasquale, Giuseppe Milazzo, Fabio Monica, Salvatore Aragona, Leonardo Ficano, Roberto Vassallo and Gastrobiota Group in Journal of International Medical Research

111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 OtorhinolaryngologyFOS: Clinical medicine110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

sj-pdf-1-imr-10.1177_03000605211073305 - Supplemental material for Guanidinoacetate���creatine in secondary progressive multiple sclerosis: a case re…

2022

Supplemental material, sj-pdf-1-imr-10.1177_03000605211073305 for Guanidinoacetate���creatine in secondary progressive multiple sclerosis: a case report by Sergej M. Ostojic, Jelena Ostojic, Dragana Zanini, Tatjana Jezdimirovic and Valdemar Stajer in Journal of International Medical Research

111199 Nutrition and Dietetics not elsewhere classifiedCardiology170199 Psychology not elsewhere classified111799 Public Health and Health Services not elsewhere classified110604 Sports MedicineFOS: Health sciences110306 Endocrinology110308 Geriatrics and Gerontology111099 Nursing not elsewhere classified111708 Health and Community Services160807 Sociological Methodology and Research Methods111702 Aged Health Care111403 Paediatrics110904 Neurology and Neuromuscular Diseases110203 Respiratory Diseases110315 OtorhinolaryngologyFOS: Clinical medicine110319 Psychiatry (incl. Psychotherapy)FOS: SociologyFOS: Psychology110599 Dentistry not elsewhere classified110323 Surgery110305 Emergency Medicine111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified111299 Oncology and Carcinogenesis not elsewhere classified110314 Orthopaedics
researchProduct

Stereochemical features of the hydrolysis of 9,10-epoxystearic acid catalysed by plant and mammalian epoxide hydrolases

2002

cis-9,10-Epoxystearic acid was used as a tool to probe the active sites of epoxide hydrolases (EHs) of mammalian and plant origin. We have compared the stereochemical features of the hydrolysis of this substrate catalysed by soluble and membrane-bound rat liver EHs, by soluble EH (purified to apparent homogeneity) obtained from maize seedlings or celeriac roots, and by recombinant soybean EH expressed in yeast. Plant EHs were found to differ in their enantioselectivity, i.e. their ability to discriminate between the two enantiomers of 9,10-epoxystearic acid. For example, while the maize enzyme hydrated both enantiomers at the same rate, the EH from soybean exhibited very high enantioselecti…

1303 BiochemistryStereochemistryMolecular Sequence DataDiol10050 Institute of Pharmacology and Toxicology610 Medicine & healthPolymerase Chain ReactionBiochemistrySubstrate Specificity1307 Cell BiologyHydrolysischemistry.chemical_compound1312 Molecular BiologyAnimalsOrganic chemistryMolecular BiologyDNA PrimersEpoxide HydrolasesMammalschemistry.chemical_classificationBase SequencebiologyChemistryHydrolysisFatty acidActive siteStereoisomerismCell BiologyPlantsRecombinant ProteinsRatsKineticsLiverMicrosomal epoxide hydrolaseEpoxide Hydrolasesbiology.protein570 Life sciences; biologyStereoselectivitySoybeansEnantiomerStearic AcidsResearch Article
researchProduct

Colorimetric quantitation of trace amounts of sodium lauryl sulfate in the presence of nucleic acids and proteins

1992

A fast and sensitive procedure for the colorimetric detection of sodium lauryl sulfate (SDS) is presented. The assay is based upon the formation of a chloroform-extractable ion pair between lauryl sulfate and methylene blue that is quantified spectrophotometrically with an estimated detection limit of 150 ng of SDS. The method is suitable for the monitoring of contaminating traces of SDS in protein or nucleic acid samples that have the potential to interfere with enzymatic manipulations such as proteolytic digest, restriction analysis, or reverse transcription. Since the procedure is extremely simple and no special equipment is required it is accessible to every researcher concerned with SD…

1303 BiochemistryTrace AmountsSodiumBiophysicschemistry.chemical_element10050 Institute of Pharmacology and Toxicology610 Medicine & healthBiochemistry1307 Cell Biologychemistry.chemical_compoundNucleic Acids1312 Molecular BiologyAnimalsSulfateColorimetryMolecular BiologyDetection limitChromatographyProteinsSodium Dodecyl SulfateCell BiologyDNAReference StandardsRatsMethylene BluechemistryNucleic acidRNA570 Life sciences; biologyCattleColorimetryQuantitative analysis (chemistry)Methylene blue1304 Biophysics
researchProduct

Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma

1998

Glutathione S-transferases (GSTs) M1 and T1 are known to be polymorphic in humans. Both polymorphisms are due to gene deletions, which are responsible for the existence of null genotypes. The gene defect of GSTT1 has been reported to be associated with an increased risk of myelodysplastic syndromes, astrocytoma and meningioma. A lack of GSTM1 was associated with tobacco smoke-induced lung and bladder cancer. In this study we examined whether the GSTT1 and/or GSTM1 homozygous null genotypes were associated with an increased risk of ovarian cancer using a multiplex polymerase chain reaction protocol. The GSTT1 null genotype was observed in 14% of the control subjects that had never suffered f…

AdultGenetic MarkersCancer Researchmedicine.medical_specialty10050 Institute of Pharmacology and Toxicology610 Medicine & healthGastroenterologyInternal medicineOvarian carcinomaGenotypemedicineCarcinomaHumans1306 Cancer ResearchFamily historyneoplasmsAgedGlutathione TransferaseAged 80 and overOvarian NeoplasmsPolymorphism GeneticBladder cancerbiologyAge FactorsAstrocytomaMiddle Agedmedicine.diseaseNeoplasm ProteinsGlutathione S-transferaseEndocrinologyOncologybiology.protein570 Life sciences; biologyFemale2730 OncologyOvarian cancerCancer Letters
researchProduct

Treatment of hypertension with a combination of nifedipine and atenolol compared with atenolol alone. Preliminary report.

1988

AdultMaleAdolescentNifedipinebusiness.industryPharmacology toxicologyBlood PressurePharmacologyMiddle AgedAtenololPharmacotherapyNifedipineAtenololPreliminary reportHypertensionmedicineHumansPharmacology (medical)Drug Therapy CombinationFemalebusinessmedicine.drugAgedDrugs
researchProduct